Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF

Raoul Orvieto

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Ovarian stimulation (OS) is one of the key factors in the success of in vitro fertilization-embryo transfer (IVF-ET), by enabling the recruitment of numerous healthy fertilizable oocytes and, thereby, multiple embryos. The Stop GnRH-agonist/GnRH-antagonist (GnRH-ag/GnRH-ant), which offers all the advantages of using long suppressive GnRH-ag, with GnRH-ant, is in my opinion a valuable addition to the armamentarium of OS protocols. It allows cycle programming, better follicular synchronization and offers successful outcome in a variety of challenging cases such as poor responders, Poseidon group 4 poor prognosis patients, those with elevated peak progesterone (P) serum levels, poor embryo quality or repeated IVF failures.

Original languageEnglish
Article number13
JournalReproductive Biology and Endocrinology
Volume21
Issue number1
DOIs
StatePublished - 1 Dec 2023
Externally publishedYes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Endocrinology
  • Obstetrics and Gynecology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF'. Together they form a unique fingerprint.

Cite this